StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Saturday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Shares of BTX stock opened at $2.57 on Friday. The firm has a 50-day moving average price of $2.34. The company has a […]